e-learning
resources
London 2016
Monday, 05.09.2016
Assessing lower airway inflammation with different tools
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Paul Brinkman (Amsterdam, Netherlands), Paul Brinkman, Niki Fens, Marianne A. van de Pol, Peter J. Sterk, Anirban Sinha
Source:
International Congress 2016 – Assessing lower airway inflammation with different tools
Session:
Assessing lower airway inflammation with different tools
Session type:
Poster Discussion
Number:
1840
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Paul Brinkman (Amsterdam, Netherlands), Paul Brinkman, Niki Fens, Marianne A. van de Pol, Peter J. Sterk, Anirban Sinha. Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control. Eur Respir J 2016; 48: Suppl. 60, 1840
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Breathprint of severe allergic asthma with SPME-GC-MS Analysis of exhaled air volatile organic compounds(Ege University translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Measuring exhaled hydrogen sulphide (eH2S) levels in asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015
Can exhaled volatile organic compounds predict asthma exacerbations in children?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Airborne concentration of limonene (a volatile organic compound (VOC)), when using a spray of 41 essential oils
Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis
Year: 2013
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Diet and alcohol affect exhaled volatile organic compounds (VOCs)
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Measurement of volatile organic compounds in exhaled breath of children of the ALL Age Asthma Cohort
Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities
Year: 2018
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Standardization of exhaled volatile organic compounds (VOCs) measurement
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Changes in exhaled volatile organic compound profile after breakfast: Implications for protocol development
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype?
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept